Skip to main content

Genetically Engineered CD4 T Cells Show Promise Across Cancers

A new treatment consisting of genetically engineered CD4 T cells could have potential in all metastatic cancers, according to Yong-Chen William Lu, PhD.
– See more at: http://www.targetedonc.com/news/genetically-engineered-cd4-t-cells-show-promise-across-tumor-types#sthash.8nSn3Rdi.dpuf
http://www.targetedonc.com/news/genetically-engineered-cd4-t-cells-show-promise-across-tumor-types

AUDIENCES

SUBJECTS

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2025 Esophageal Cancer Education Foundation- by domino